Jane Street Group, LLC Uro Gen Pharma Ltd. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 30,718 shares of URGN stock, worth $351,721. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,718

Previous 60,316 49.07%

Holding current value

$351,721

Previous $1.01 Million 61.46%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.7 - $17.92 $375,894 - $530,396	-29,598 Reduced 49.07%	30,718 $390,000
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $482,075 - $727,660	37,899 Added 169.06%	60,316 $1.01 Million
Q1 2024 May 15, 2024	BUY	$13.81 - $19.33 $80,208 - $112,268	5,808 Added 34.97%	22,417 $336,000
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $71,220 - $104,373	6,552 Added 65.15%	16,609 $249,000
Q3 2023 Nov 14, 2023	SELL	$8.84 - $22.64 $29,154 - $74,666	-3,298 Reduced 24.69%	10,057 $140,000
Q2 2023 Aug 14, 2023	SELL	$8.75 - $14.29 $625,756 - $1.02 Million	-71,515 Reduced 84.26%	13,355 $138,000
Q1 2023 May 15, 2023	BUY	$7.99 - $11.02 $678,111 - $935,267	84,870 New	84,870 $784,000
Q4 2020 Feb 17, 2021	SELL	$17.54 - $25.43 $381,284 - $552,797	-21,738 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$18.81 - $26.42 $9,931 - $13,949	-528 Reduced 2.37%	21,738 $419,000
Q2 2020 Aug 17, 2020	BUY	$16.5 - $29.7 $128,650 - $231,570	7,797 Added 53.89%	22,266 $582,000
Q1 2020 May 15, 2020	SELL	$13.68 - $34.6 $235,980 - $596,850	-17,250 Reduced 54.38%	14,469 $258,000
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $669,588 - $1.11 Million	31,719 New	31,719 $1.06 Million
Q3 2018 Nov 14, 2018	SELL	$41.65 - $51.7 $190,048 - $235,907	-4,563 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$48.35 - $65.33 $220,621 - $298,100	4,563 New	4,563 $227,000

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Uro Gen Pharma Ltd. Transaction History